NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
2.91
Dollar change
+0.04
Percentage change
1.39
%
Index- P/E- EPS (ttm)-3.81 Insider Own2.02% Shs Outstand2.58M Perf Week8.99%
Market Cap7.52M Forward P/E- EPS next Y-2.85 Insider Trans-2.79% Shs Float2.53M Perf Month20.25%
Enterprise Value-0.18M PEG- EPS next Q-0.63 Inst Own7.80% Short Float2.41% Perf Quarter41.95%
Income-6.09M P/S752.00 EPS this Y19.14% Inst Trans0.40% Short Ratio0.60 Perf Half Y16.40%
Sales0.01M P/B0.93 EPS next Y5.00% ROA-67.79% Short Interest0.06M Perf YTD25.97%
Book/sh3.12 P/C0.98 EPS next 5Y- ROE-70.45% 52W High6.90 -57.83% Perf Year-17.09%
Cash/sh2.98 P/FCF- EPS past 3/5Y- 75.38% ROIC-75.55% 52W Low1.69 72.19% Perf 3Y-54.32%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-49.95% -41.85% Gross Margin-738.27% Volatility18.17% 11.08% Perf 5Y-87.07%
Dividend TTM- EV/Sales-18.00 EPS Y/Y TTM-1.79% Oper. Margin-44865.66% ATR (14)0.34 Perf 10Y-
Dividend Ex-Date- Quick Ratio27.39 Sales Y/Y TTM55.56% Profit Margin-43500.24% RSI (14)55.65 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio27.39 EPS Q/Q-12.87% SMA2010.59% Beta4.94 Target Price20.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA5025.88% Rel Volume8.22 Prev Close2.87
Employees4 LT Debt/Eq0.00 EarningsMay 28 SMA2000.80% Avg Volume101.59K Price2.91
IPONov 06, 2015 Option/ShortNo / Yes EPS/Sales Surpr.-59.62% - Trades Volume835,370 Change1.39%
Jul-11-25 08:01AM
Mar-25-25 12:00PM
09:40AM
Mar-20-25 07:50AM
Mar-06-25 08:10AM
08:00AM Loading…
Feb-20-25 08:00AM
Feb-14-25 07:00AM
Feb-11-25 09:25AM
Feb-05-25 08:25AM
Jan-30-25 09:25AM
Nov-13-24 09:00AM
Oct-24-24 08:21AM
Oct-23-24 08:00AM
Jul-24-24 09:00AM
Jul-10-24 08:30AM
08:30AM Loading…
Jun-24-24 08:30AM
May-13-24 10:54AM
Mar-27-24 09:00AM
Mar-07-24 11:04AM
09:15AM
Mar-06-24 07:00AM
Dec-20-23 09:35AM
Nov-15-23 08:00AM
Oct-10-23 08:00AM
Sep-19-23 08:00AM
Aug-24-23 10:45AM
Jul-13-23 09:00AM
Jun-28-23 08:00AM
Jun-12-23 08:01AM
08:00AM
12:30PM Loading…
Jun-09-23 12:30PM
May-31-23 08:00AM
May-22-23 08:30AM
May-18-23 08:00AM
May-14-23 08:13AM
Apr-12-23 08:00AM
Apr-04-23 08:00AM
Mar-23-23 08:00AM
Mar-21-23 08:00AM
Mar-07-23 08:00AM
Feb-14-23 08:00AM
Feb-08-23 08:00AM
Nov-03-22 07:30AM
Oct-20-22 08:00AM
Sep-26-22 08:00AM
Jul-28-22 07:30AM
Jun-15-22 08:30AM
Apr-29-22 08:40AM
Apr-20-22 08:30AM
Apr-12-22 08:30AM
Mar-31-22 08:30AM
Mar-23-22 08:30AM
Mar-10-22 08:30AM
Mar-08-22 08:30AM
Mar-02-22 08:30AM
Jan-20-22 07:15AM
Nov-09-21 04:45PM
Oct-12-21 08:15AM
Oct-01-21 08:15AM
Sep-16-21 07:45AM
Aug-09-21 04:43PM
Jul-20-21 07:45AM
Jun-22-21 07:45AM
Jun-17-21 07:00AM
Jun-09-21 08:18AM
May-24-21 07:45AM
May-20-21 08:45AM
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finger Michael H.DirectorFeb 19 '25Sale5.757504,312351Feb 20 07:23 PM
Finger Michael H.DirectorFeb 18 '25Sale5.007503,7501,101Feb 20 07:23 PM